Brain Health

The Pharmacy Times® Brain Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to neural development, plasticity, functioning, and recovery associated with aging.

Latest News

Valbenazine capsules -- Image credit: luchschenF | stock.adobe.com
48-Week Data Show Efficacy of Valbenazine in Patients With Tardive Dyskinesia and Schizophrenic, Mood Disorders

March 26th 2025

About 59.2% of patients with tardive dyskinesia (TD) who completed the 48-week trial achieved remission.

Vibrant Neural Connections and Brain Activity
FDA Grants Orphan Drug Designation to Radiprodil for GRIN-Related Neurodevelopmental Disorder

March 19th 2025

FDA logo on a smartphone -- Image credit: gguy | stock.adobe.com
FDA Grants Orphan Drug Designation to EN001 for Neuromuscular Disorder, CMT Disease

March 10th 2025

FDA webpage -- Image credit: IB Photography | stock.adobe.com
FDA Removes Clozapine REMS Requirement to Report Patients’ Absolute Neutrophil Count

March 6th 2025

Encephalopathy spelling using wooden blocks | Image Credit: © H_Ko - stock.adobe.com
CDC Releases Reports of Encephalopathy in Children With Influenza-Associated Mortality

March 3rd 2025

More News